Home > Coller Institute News > Silicon Dragon Returns to Israel Feb. 20, 2017, 15:00-20:00, at the Tel Aviv Stock Exchange

Silicon Dragon Returns to Israel Feb. 20, 2017, 15:00-20:00, at the Tel Aviv Stock Exchange

“硅谷之龙” (Silicon Dragon) 回到以色列

Silicon Dragon returns to Israel for its second forum focused on the tech triangle — China, Israel, US.

The program features panels with leading venture capitalists and dealmakers and tech chats with entrepreneurs running innovative emerging companies with China-Israeli ties. The event will be held at the Tel Aviv Stock Exchange and is supported by Sidley Austin, OurCrowd, the Coller Institute of Venture, Israeli Advanced Technology Industries, Israel-Asia Center and Israel-Asia Chamber of Commerce.

Prof. Yesha Sivan, CIV Executive Director, will moderate a panel at the event that promises to be a high-class event, featuring prominent Israeli and Chinese VCs, founders and corporates.

The Coller Institute of Venture is pleased to offer a 25% discount on tickets to Silicon Dragon Israel 2017:

Link to sign up:

https://silicondragonisrael2017.eventbrite.com

Code for 25% discount: SDIsrael17Coller

Silicon Dragon is a partner of #CIV2017HK, the annual conference of the Coller Institute of Venture in Hong Kong and Shenzhen (22-26 April 2017).

Check Also

Structured Exits: A Potential New Source of Funding for Life Science Startups A Guest Post by Leslie Mitts

Structured exits are an important funding structure for new ventures. Rather than relying solely on the upside from an exit, structured exits can rely on the venture’s anticipated cash flow, or percentage of milestone payments, to repay the investor. For investors, they can offer reduced risk with the possibility of an upside; for ventures, they provide a new source of growth capital and less dilution. For life-sciences companies caught in the “death valley” between seed grants and venture capital eligibility, structured exits - carefully adapted and applied - can be a new alternative or complement to bridge loans, incubators, strategic investors, and non-dilutive funding from government sources. Read more in a guest post by Leslie Mitts, featuring Att. David Gitlin, on the CIV website.